ASSEMBLY BIOSCIENCES INC (ASMB)
US0453962070 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.84M | 52.40M | 45.60M | 59.40M | 46.70M | |||
| Marketable Securities | 110.41M | 39.20M | 101.00M | 157.00M | 227.30M | |||
| Receivables | 43.00K | 900.00K | 300.00K | 1.20M | 3.40M | |||
| Other Current Assets | 3.50M | 4.40M | 7.20M | 6.90M | 5.40M | |||
| Total Current Assets | 133.79M | 97.00M | 154.20M | 224.50M | 282.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.72M | 3.90M | 7.20M | 10.70M | 13.80M | |||
| Investments And Advances | N/A | 0.00 | 28.00M | N/A | N/A | |||
| Goodwill | N/A | N/A | 0.00 | 12.60M | 12.60M | |||
| Intangibles | N/A | N/A | 0.00 | 29.00M | 29.00M | |||
| Other Non-Current Assets | 312.00K | 900.00K | 1.70M | 6.40M | 1.70M | |||
| Total Non-Current Assets | 3.04M | 4.80M | 36.90M | 58.80M | 57.10M | |||
| TOTAL ASSETS | 136.82M | 101.80M | 191.10M | 283.30M | 339.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.85M | 13.80M | 13.40M | 19.80M | 16.30M | |||
| Accounts Payable | 461.00K | 2.50M | 2.70M | 4.60M | 1.70M | |||
| Other Current Liabilities | 30.91M | N/A | N/A | 0.00 | 6.40M | |||
| Total Current Liabilities | 39.23M | 16.30M | 16.10M | 24.40M | 24.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 2.50M | 2.50M | |||
| Other Non-Current Liabilities | 56.50M | 2.80M | 6.10M | 15.70M | 39.70M | |||
| Total Non-Current Liabilities | 56.50M | 2.80M | 6.00M | 18.30M | 42.30M | |||
| TOTAL LIABILITIES | 95.73M | 19.10M | 22.10M | 42.70M | 66.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -785.75M | -724.50M | -631.40M | -501.60M | -439.40M | |||
| Additional Paid In Capital | 826.92M | 807.90M | 800.70M | 742.40M | 712.80M | |||
| Common Shares | 5.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 5.48M | 48.90M | 48.10M | 34.00M | 32.60M | |||
| Tangible Book Value per Share | 7.50 | 1.69 | 3.51 | 5.85 | 7.10 | |||
| Total Shareholders' Equity | 41.10M | 82.70M | 168.90M | 240.60M | 273.20M | |||
| TOTAL LIABILITIES AND EQUITY | 136.82M | 101.80M | 191.10M | 283.30M | 339.90M | |||
| Statistics | ||||||||
| Current Ratio | 3.41 | 5.95 | 9.58 | 9.20 | 11.59 | |||
| Return On Assets (ROA) | -44.75% | -91.44% | -67.95% | -21.94% | -28.72% | |||
| Return On Equity (ROE) | -148.98% | -112.56% | -76.89% | -25.83% | -35.74% | |||
All data in USD